SBIR-TT RFP: Transcatheter Cerclage Mitral Valve Annuloplasty
The National Heart, Lung, and Blood Institute (NHLBI)
invites small business concerns to submit research proposals for the
development of commercial-grade interventional tools to make a
clinical annuloplasty procedure for the treatment of secondary
mitral valve regurgitation simple and safe, including device and
regulatory development, followed by early clinical testing.
This is an SBIR Technology Transfer contract topic from the NHLBI.
This is a new program whereby inventions from the NHLBI Division of
Intramural Research are licensed to qualified small businesses with
the intent that those businesses develop these inventions into
commercial products that benefit the public. The contractor funded
under this NHLBI SBIR contract topic can work in a collaborative
manner with the NHLBI Inventor(s) regarding catheter designs,
procedure techniques, clinical considerations, and discussions
during the entire award period.
View the solicitation.
Pre-submission Meeting for Applicants
A pre-submission meeting was held on June 14th, 2012. NHLBI staff explained the objectives of the solicitation, described the applicable NIH
technology, and answered questions related to licensing and the
View a recording of the webinar.
Frequently Asked Questions
Questions and Answers from the pre-submission meeting are now
available with the
solicitation. If you have
additional questions, they should be emailed to
Last Updated May 2012